68 related articles for article (PubMed ID: 32606581)
1. A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease.
Jerkins G; Greiner JV; Tong L; Tan J; Tauber J; Mearza A; Srinivasan S
Clin Ophthalmol; 2020; 14():1665-1673. PubMed ID: 32606581
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study.
Labetoulle M; Schmickler S; Galarreta D; Böhringer D; Ogundele A; Guillon M; Baudouin C
Clin Ophthalmol; 2018; 12():2499-2508. PubMed ID: 30584269
[TBL] [Abstract][Full Text] [Related]
3. Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study.
Bickle K; Miller JR; Tauber J; Awisi-Gyau D
Ophthalmol Ther; 2024 Feb; 13(2):481-494. PubMed ID: 38079084
[TBL] [Abstract][Full Text] [Related]
4. A prospective, multicenter, noninterventional study of Optive Plus(®) in the treatment of patients with dry eye: the prolipid study.
Kaercher T; Thelen U; Brief G; Morgan-Warren RJ; Leaback R
Clin Ophthalmol; 2014; 8():1147-55. PubMed ID: 24970993
[TBL] [Abstract][Full Text] [Related]
5. Homoeopathic eye drops in the treatment of mild-to-moderate dry eye disease: Randomised, prospective, multicentre, single-masked study.
Mortemousque B; Pisella PJ; Salaun N; Lemaire N; Chanel I
Eur J Ophthalmol; 2023 Dec; ():11206721231216129. PubMed ID: 38062637
[TBL] [Abstract][Full Text] [Related]
6. Systane lubricant eye drops in the management of ocular dryness.
Benelli U
Clin Ophthalmol; 2011; 5():783-90. PubMed ID: 21750611
[TBL] [Abstract][Full Text] [Related]
7. The Effectiveness and Safety of a Novel Crosslinked Hyaluronate Canalicular Gel Occlusive Device for Dry Eye.
Packer M; Lindstrom R; Thompson V; Parekh JG; Gupta P; Nijm LM; Donnenfeld E
J Cataract Refract Surg; 2024 Jun; ():. PubMed ID: 38875184
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial.
Yeu E; Silverstein S; Guillon M; Schulze MM; Galarreta D; Srinivasan S; Manoj V
Clin Ophthalmol; 2020; 14():2561-2570. PubMed ID: 32943837
[TBL] [Abstract][Full Text] [Related]
9. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial.
Silverstein S; Yeu E; Tauber J; Guillon M; Jones L; Galarreta D; Srinivasan S; Manoj V
Clin Ophthalmol; 2020; 14():3167-3177. PubMed ID: 33116367
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study.
Aragona P; Benítez-Del-Castillo JM; Coroneo MT; Mukherji S; Tan J; Vandewalle E; Vingrys A; Liu H; Carlisle-Wilcox C; Vehige J; Simmons PA
Clin Ophthalmol; 2020; 14():2951-2963. PubMed ID: 33061281
[TBL] [Abstract][Full Text] [Related]
11. A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare
Karpecki P; Wirta D; Osmanovic S; Dhamdhere K
Clin Ophthalmol; 2020; 14():4551-4559. PubMed ID: 33408457
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of castor oil in managing blepharitis, meibomian gland dysfunction and dry eye.
Sandford EC; Muntz A; Craig JP
Clin Exp Optom; 2021 Apr; 104(3):315-322. PubMed ID: 33037703
[TBL] [Abstract][Full Text] [Related]
13. Formulation Considerations for the Management of Dry Eye Disease.
Agarwal P; Craig JP; Rupenthal ID
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33546193
[TBL] [Abstract][Full Text] [Related]
14. The effect of hydroxypropyl-guar nanoemulsion on signs and symptoms of dry eye.
Markoulli M; Wong K; Jia T; Siddireddy JS; Briggs N; Tan J
Cont Lens Anterior Eye; 2022 Dec; 45(6):101736. PubMed ID: 35835650
[TBL] [Abstract][Full Text] [Related]
15. Impact of dry eye disease treatment on patient quality of life.
Lin CW; Lin MY; Huang JW; Wang TJ; Lin IC
Front Med (Lausanne); 2024; 11():1305579. PubMed ID: 38482530
[TBL] [Abstract][Full Text] [Related]
16. Artificial Tears: A Systematic Review.
Semp DA; Beeson D; Sheppard AL; Dutta D; Wolffsohn JS
Clin Optom (Auckl); 2023; 15():9-27. PubMed ID: 36647552
[TBL] [Abstract][Full Text] [Related]
17. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
Srinivasan S; Williams R
Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
[TBL] [Abstract][Full Text] [Related]
18. Assessment of a Cationic Emulsion to Control the Tear Film Evaporation Rate.
Abusharha A
Clin Optom (Auckl); 2021; 13():243-248. PubMed ID: 34408523
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Evaporative Dry Eye With Meibomian Gland Dysfunction in Model Mice by Treatment With Ophthalmic Solution Containing Mineral Oil.
Watanabe K; Yoshida M; Okumura T; Sassa T; Kihara A; Uchiyama A
Transl Vis Sci Technol; 2021 Apr; 10(4):21. PubMed ID: 34003999
[TBL] [Abstract][Full Text] [Related]
20. Dry eye: why artificial tears are not always the answer.
Kim M; Lee Y; Mehra D; Sabater AL; Galor A
BMJ Open Ophthalmol; 2021; 6(1):e000697. PubMed ID: 33907713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
